Deoxy-Mannose Derivatives as Potential Immune System Boosters in SARS-CoV-2 Infections - Archive ouverte HAL Accéder directement au contenu
Pré-Publication, Document De Travail Année : 2020

Deoxy-Mannose Derivatives as Potential Immune System Boosters in SARS-CoV-2 Infections

Résumé

Coronaviruses such as SARSCoV-2 are spherical infectious agents covered with out-pointing protein spicules. These spicules are coated with the host's glycans that display immunoevasion epitopes in the circulating medium of the infected body. The post-transcriptional construction of this external camouflaging glycan envelope provides the virus with an elusive protection from the immune system. The poly-mannose glycans are synthesized in the infected cells' endoplasmic reticulum and transferred onto the S-protein N-glycosylation sites of the spicules at the end of the virus reproduction cycle. The core structure of these glycans is composed of branched mannoses on an asparagine N-glycosylated chitobiose root. Deoxy-D-mannoses and derivatives such as fluoro-or chloro-substituted analogues possess the structural features to be potentially recognised and used by cytoplasm or endoplasmic reticulum oligo-mannose synthase enzymes during the construction of the dolichol-phosphate glycan biosynthesis. If incorporated onto the growing chitobiose rooted disaccharide, these residues would inhibit further growth of the terminal poly-mannose structure by introducing-OH glycosylation site deficiencies at key branching or elongating positions. These deficiencies would then prevent full growth of the oligo-mannose terminal glycan. The presence of shorter and incomplete glycan epitopes on the released virus spicules would leave a larger surface of the S-protein uncovered. Consequently, the virus antigenic sites would be more exposed (accessible) to the circulating antibodies of the host's immune system.
Fichier principal
Vignette du fichier
DeoxyhaloMan.pdf (768.49 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03020255 , version 1 (23-11-2020)

Licence

Paternité

Identifiants

  • HAL Id : hal-03020255 , version 1

Citer

Christophe Bliard. Deoxy-Mannose Derivatives as Potential Immune System Boosters in SARS-CoV-2 Infections. 2020. ⟨hal-03020255⟩
75 Consultations
89 Téléchargements

Partager

Gmail Facebook X LinkedIn More